Pharmaceutical R&D: Looking for a Needle in a Haystack? Torch the Haystack.

15
TORCHING THE HAYSTACK Models of Drug Development Dennis Lendrem

description

Based on Lendrem DW, Lendrem BC 2013 Torching the Haystack, Drug Discovery Today, 2013

Transcript of Pharmaceutical R&D: Looking for a Needle in a Haystack? Torch the Haystack.

Page 1: Pharmaceutical R&D: Looking for a Needle in a Haystack?  Torch the Haystack.

TORCHING THE HAYSTACKModels of Drug Development

Dennis Lendrem

Page 2: Pharmaceutical R&D: Looking for a Needle in a Haystack?  Torch the Haystack.

Torching the Haystack

•1990• Business Process Reengineering prompted a

reinvention of pharmaceutical development processes. • Minimizing time to market identified as the key to

improving R&D productivity.• By placing development tasks in parallel, wherever

possible, we minimize time to market for successful molecules.

Page 3: Pharmaceutical R&D: Looking for a Needle in a Haystack?  Torch the Haystack.

Torching the Haystack

Before Development Speed Initiative

6321 4 5

3

2

1 64

5

After Development Speed Initiative

Time to Market

Page 4: Pharmaceutical R&D: Looking for a Needle in a Haystack?  Torch the Haystack.

Torching the Haystack

BUT

Page 5: Pharmaceutical R&D: Looking for a Needle in a Haystack?  Torch the Haystack.

Torching the Haystack

MOST …molecules don’t make it to market

10%

Page 6: Pharmaceutical R&D: Looking for a Needle in a Haystack?  Torch the Haystack.

Torching the Haystack

• We optimized the R&D process around an event which happens less than 10% of the time.

Page 7: Pharmaceutical R&D: Looking for a Needle in a Haystack?  Torch the Haystack.

Torching the Haystack• By placing tasks in parallel to reduce cycle time we

inadvertently:• Increased R&D costs• Increased late-stage attrition rates, and• Increased expected time to market

Lendrem DW, Lendrem BC Torching the Haystack: Modelling fast-fail strategies in drug development. Drug Discov Today. 2013 Apr;18(7-8):331-6. http://dx.doi.org/10.1016/j.drudis.2012.11.011

p

1 - p

β

1

1-β1

1-α1

α

1

β

2

1-β2

C 2

C 2

C 2

C 2

C 0

C 1

C 1

C 0

C 1

C 1

1-αi

αi C i

C i

C i

C i

β

i

1-βi

1-α2

α

2

Stage i=0 Stage i=1 Stage i=2.... ...Stage i=m

.......

.......

a

b

c

d

Page 8: Pharmaceutical R&D: Looking for a Needle in a Haystack?  Torch the Haystack.

• Example

Torching the Haystack

Time

New 2 2 2 + 2 = 4

Old 1 5 1 + 5 = 6

Lendrem DW More haste, less development speed. Scrip Magazine. Dec 1995, 22-23.

Page 9: Pharmaceutical R&D: Looking for a Needle in a Haystack?  Torch the Haystack.

• Example

If p=0.10 then the average number of drugs tested before the first success = 1/p = 10

So the average time to launch the first drug:

= (10 x 1) + 5 = 15 years

= (10 x 2) + 2 = 22 years

Torching the Haystack

New

Old

New 2 2 2 + 2 = 4

Old 1 5 1 + 5 = 6

Lendrem DW More haste, less development speed. Scrip Magazine. Dec 1995, 22-23.

Page 10: Pharmaceutical R&D: Looking for a Needle in a Haystack?  Torch the Haystack.

Torching the Haystack

• Conclusion?• For high risk projects, the expected time to market is

actually SHORTER for the serial process EVEN THOUGH THE CYCLE TIME is LONGER.

• This is the Development Speed Paradox

Lendrem DW, Lendrem BC The Development Speed Paradox: Can increasing development speed reduce R&D productivity? Drug Discov Today. 2014 http://dx.doi.org/10.1016/j.drudis.2013.09.002

The faster you go the longer it takes.

Page 11: Pharmaceutical R&D: Looking for a Needle in a Haystack?  Torch the Haystack.

# screened = 38# discovered = 3# launched = 3

# screened = 58# discovered = 5# launched = 4

10

20

30

40

50

10

20

30

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

Cycle Time = 2+2 = 4 yrs Cycle Time = 1+5 = 6 yrs

Years

The Tetris Model

Page 12: Pharmaceutical R&D: Looking for a Needle in a Haystack?  Torch the Haystack.

Torching the Haystack• By placing tasks in parallel to reduce cycle time we

inadvertently:• Increased R&D costs• Increased late-stage attrition rates• Increased expected time to market

• As a result, the industry became really slick at delivering late-stage failures to the market place, precipitating the current R&D productivity crisis.

Lendrem DW, Lendrem BC Torching the Haystack: Modelling fast-fail strategies in drug development. Drug Discov Today. 2013 Apr;18(7-8):331-6. http://dx.doi.org/10.1016/j.drudis.2012.11.011

Page 13: Pharmaceutical R&D: Looking for a Needle in a Haystack?  Torch the Haystack.

Torching the Haystack

• The M25 Effect• Reducing Development Speed may actually increase

R&D throughput. • After London’s major orbital motorway where speed

limits were first reduced in the UK in order to increase traffic throughput.

Lendrem DW, Lendrem BC The Development Speed Paradox: Can increasing development speed reduce R&D productivity? Drug Discov Today. 2014 http://dx.doi.org/10.1016/j.drudis.2013.09.002

Page 14: Pharmaceutical R&D: Looking for a Needle in a Haystack?  Torch the Haystack.

Torching the Haystack

Looking for a needle in a haystack?• Get the science right. Build opportunities to kill

molecules earlier in the development cycle.

• Assays that prevent molecules from entering the development process.

• Assays that allow elimination of molecules early in the development process.

Page 15: Pharmaceutical R&D: Looking for a Needle in a Haystack?  Torch the Haystack.

Torching the Haystack

• Thanks• Richard Peck (Lilly)• Fred Snikeris (Quintiles)• Stephen Senn (CRP-Sante)• Clare Lendrem (NCL)• Frank Bonner (NCL)• Wan-Fai Ng (NCL)• John Isaacs (NCL)• MRG